Title:
SMALL MOLECULE INHIBITOR AGAINST NASOPHARYNGEAL CARCINOMA, PREPARATION METHOD FOR COMPOUND AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/088285
Kind Code:
A1
Abstract:
A small molecule inhibitor targeting EB virus antigen protein, and/or a pharmaceutical composition comprising same, capable of being used for treating diseases caused by EB virus infection, such as, but not limited to, cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis, especially nasopharyngeal carcinoma. Further provided are a small molecule inhibitor against nasopharyngeal carcinoma, and/or a pharmaceutical composition comprising same, capable of being used for treating nasopharyngeal carcinoma.
Inventors:
ZHU ZHENDONG (US)
XU ZHENGSHUANG (CN)
LI TING (CN)
CHE CHAO (CN)
REN XINGYE (CN)
CHEN SIGUI (CN)
ZHANG JIAYIN (CN)
ZHANG BEN (CN)
YANG QI (CN)
ZHANG CHUANBING (CN)
YANG ZHEN (CN)
XU ZHENGSHUANG (CN)
LI TING (CN)
CHE CHAO (CN)
REN XINGYE (CN)
CHEN SIGUI (CN)
ZHANG JIAYIN (CN)
ZHANG BEN (CN)
YANG QI (CN)
ZHANG CHUANBING (CN)
YANG ZHEN (CN)
Application Number:
PCT/CN2022/132174
Publication Date:
May 25, 2023
Filing Date:
November 16, 2022
Export Citation:
Assignee:
SHENZHEN BAY LABORATORY (CN)
UNIV PEKING SHENZHEN GRADUATE SCHOOL (CN)
UNIV PEKING SHENZHEN GRADUATE SCHOOL (CN)
International Classes:
C07D205/04; A61K31/397; A61K31/4025; A61K31/404; A61K31/44; A61P19/02; A61P29/00; A61P31/22; A61P35/00; C07C63/49; C07C65/26; C07D213/30; C07D401/02; C07D401/14; C07D403/14; C07D409/02
Domestic Patent References:
| WO2010059393A1 | 2010-05-27 |
Foreign References:
| CN113754541A | 2021-12-07 | |||
| CN105934425A | 2016-09-07 | |||
| CN107848964A | 2018-03-27 |
Attorney, Agent or Firm:
GLOBAL LAW OFFICE (CN)
Download PDF: